
Teslexivir
CAS No. 1075798-37-6
Teslexivir( BTA074 | BTA-074 | AP611074 | AP-611074 )
Catalog No. M10309 CAS No. 1075798-37-6
A first-in-class, small molecule protein-protein inhibitor of the interaction between the E1 and E2 proteins of HPV types 6 and 11.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 1323 | Get Quote |
![]() ![]() |
50MG | 2682 | Get Quote |
![]() ![]() |
100MG | 3600 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameTeslexivir
-
NoteResearch use only, not for human use.
-
Brief DescriptionA first-in-class, small molecule protein-protein inhibitor of the interaction between the E1 and E2 proteins of HPV types 6 and 11.
-
DescriptionA first-in-class, small molecule protein-protein inhibitor of the interaction between the E1 and E2 proteins of HPV types 6 and 11; is being evaluated as a topical treatment for genital warts, condyloma or other HPV infections.HPV Infection Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsBTA074 | BTA-074 | AP611074 | AP-611074
-
PathwayMicrobiology/Virology
-
TargetHPV
-
RecptorHPV
-
Research AreaInfection
-
IndicationHPV Infection
Chemical Information
-
CAS Number1075798-37-6
-
Formula Weight642.594
-
Molecular FormulaC35H36BrN3O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(O)C1=CC(Br)=C(CC(NN(C2=CC=C(CC3=CC=CC=C3)C=C2)C4=C(N5CCCCC5)C=CC=C4C)=O)C=C1OC
-
Chemical Name4-(2-{2-(4-benzylphenyl)-2-[2-methyl-6-(piperidin-1-yl)phenyl]hydrazin-1-yl}-2-oxoethyl)-5-bromo-2-methoxybenzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
HPV16 E7 (86-93)
This is amino acids 86 to 93 fragment of the human papilloma virus (HPV) type 16 oncoprotein E7. This HPV16-encoded peptide has very high affinity of binding to the HLA-A*0201 molecule.This immunogenic fragment may be used in vaccines for the prevention and treatment of cervical carcinoma.
-
HPV16-E711-20 epitop...
HPV16-E711-20 epitope is a well-known HLA-A*0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro.
-
Teslexivir
A first-in-class, small molecule protein-protein inhibitor of the interaction between the E1 and E2 proteins of HPV types 6 and 11.